TipRanks
Advertisement
Advertisement
Vivesto completes dog enrollment in Paccal Vet hemangiosarcoma study ahead of Q3 data
PremiumCompany AnnouncementsVivesto completes dog enrollment in Paccal Vet hemangiosarcoma study ahead of Q3 data
3M ago
Vivesto’s Cantrixil Clears Key Preclinical Hurdle With Positive i.v. Safety Data
Premium
Company Announcements
Vivesto’s Cantrixil Clears Key Preclinical Hurdle With Positive i.v. Safety Data
4M ago
Vivesto names seasoned life science financier Björn Svanström as new CFO
Premium
Company Announcements
Vivesto names seasoned life science financier Björn Svanström as new CFO
4M ago
Vivesto Calls 2026 AGM With Reverse Share Split on Agenda
PremiumCompany AnnouncementsVivesto Calls 2026 AGM With Reverse Share Split on Agenda
6M ago
Vivesto Advances Cantrixil With First Dogs Dosed in PK/Toxicology Study
Premium
Company Announcements
Vivesto Advances Cantrixil With First Dogs Dosed in PK/Toxicology Study
7M ago
Vivesto Boosts Share Count After Rights and Set-Off Issues
Premium
Company Announcements
Vivesto Boosts Share Count After Rights and Set-Off Issues
7M ago
Vivesto Engages Liberi Group to Boost Partnering for Key Oncology Programs
PremiumCompany AnnouncementsVivesto Engages Liberi Group to Boost Partnering for Key Oncology Programs
10M ago
Vivesto AB Showcases Promising Oncology Developments in Business Update
Premium
Company Announcements
Vivesto AB Showcases Promising Oncology Developments in Business Update
11M ago
Vivesto AB Announces SEK 53.8 Million Rights Issue to Fund Key Projects
Premium
Company Announcements
Vivesto AB Announces SEK 53.8 Million Rights Issue to Fund Key Projects
11M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―